SAN FRANCISCO (MarketWatch) -- Endo Pharmaceuticals Holdings Inc. said late Wednesday that Chief Executive Carol Ammon will step down from her position, but will remain chairwoman of its board of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results